SEC Form 4 · accession 0001209191-18-006615
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen Merrigan
Director
Period of report
Jan 30, 2018
Accepted (ET)
Feb 1, 2018 · 8:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 31, 2018 | M | 21,941 | — | A | 21,941 | D | |
| Common StockF1 | Jan 31, 2018 | M | 3,740 | — | A | 25,681 | D | |
| Common StockF1 | Jan 31, 2018 | M | 36,850 | — | A | 62,531 | D | |
| Common StockF1 | Jan 31, 2018 | M | 14,201 | — | A | 76,732 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 30, 2018 | A | 14,201 | A | — | — | Common Stock | 14,201 | 14,201 | D |
| Restricted Stock UnitsF1,F3 | — | Jan 31, 2018 | M | 21,941 | D | — | — | Common Stock | 21,941 | 13,965 | D |
| Restricted Stock UnitsF1,F4 | — | Jan 31, 2018 | M | 3,740 | D | — | — | Common Stock | 3,740 | 0 | D |
| Restricted Stock UnitsF1,F5 | — | Jan 31, 2018 | M | 36,850 | D | — | — | Common Stock | 36,850 | 0 | D |
| Restricted Stock UnitsF1,F2 | — | Jan 31, 2018 | M | 14,201 | D | — | — | Common Stock | 14,201 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock, which settled upon the termination of the reporting person's service as a director.
- F2The restricted stock units vested with respect to 100% of the total shares subject to the grant on January 30, 2018. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
- F3The restricted stock units vested with respect to 1/3rd of the total shares on the first anniversary of the vesting commencement date of March 22, 2016, and with respect to 1/24th of the remaining shares subject to the grant monthly thereafter for 24 months. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
- F4The restricted stock units vested with respect to 100% of the total shares subject to the grant on the date of the 2016 annual stockholder meeting. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
- F5The restricted stock units vested with respect to 100% of the total shares subject to the grant on the date of the 2017 annual stockholder meeting. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.